NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $756,412 | +11.0% | 7,426 | +9.9% | 0.10% | +12.6% |
| Q2 2023 | $681,546 | +41.6% | 6,754 | +29.1% | 0.09% | +31.8% |
| Q1 2023 | $481,160 | +99.2% | 5,230 | +96.5% | 0.07% | +69.2% |
| Q4 2022 | $241,497 | +13.4% | 2,662 | -4.9% | 0.04% | 0.0% |
| Q3 2022 | $213,000 | -29.7% | 2,800 | -21.9% | 0.04% | -29.1% |
| Q2 2022 | $303,000 | +7.8% | 3,587 | +12.0% | 0.06% | +12.2% |
| Q1 2022 | $281,000 | +26.6% | 3,203 | +26.0% | 0.05% | +16.7% |
| Q4 2021 | $222,000 | -7.1% | 2,542 | -12.9% | 0.04% | -23.6% |
| Q3 2021 | $239,000 | -12.1% | 2,919 | -2.0% | 0.06% | -16.7% |
| Q2 2021 | $272,000 | +16.7% | 2,978 | +9.1% | 0.07% | -2.9% |
| Q1 2021 | $233,000 | +2.2% | 2,730 | +13.0% | 0.07% | -12.8% |
| Q4 2020 | $228,000 | +4.6% | 2,416 | -3.4% | 0.08% | -12.4% |
| Q3 2020 | $218,000 | 0.0% | 2,502 | +0.2% | 0.09% | -10.1% |
| Q2 2020 | $218,000 | – | 2,496 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |